Global Generative AI in Healthcare Market Size & Trends Report Segmented by Application (Drug Discovery & Development, Imaging, Diagnostics, Personalized Medicine), End-User (Pharma & Biotech and Medical Device Companies, Payers, Providers) & Regional Forecast to 2031

Generative AI in healthcare refers to the application of advanced artificial intelligence models capable of creating new content, insights, and data by learning patterns from vast healthcare datasets. Powered by large language models (LLMs), deep learning, and neural networks, these systems can generate clinical documentation, medical summaries, diagnostic recommendations, synthetic patient data, medical images, and personalized treatment insights. Generative AI enhances clinical decision-making, streamlines administrative workflows, accelerates drug discovery, supports medical research, and improves patient engagement. As healthcare organizations increasingly adopt AI-driven solutions, generative AI is becoming a transformative technology that improves operational efficiency, enables precision medicine, and enhances overall healthcare delivery.

Rapid advancements in AI technology to drive market growth

The rapid advancements in AI technology are pivotal in driving the growth of generative AI in the healthcare market. Breakthroughs in deep learning, natural language processing (NLP), and neural networks enable AI systems to analyse vast amounts of medical data with unprecedented accuracy. These technologies facilitate the automation of complex tasks such as drug discovery, diagnostic imaging, and personalized treatment planning, improving patient outcomes and operational efficiency. Enhanced AI algorithms can predict disease progression, optimize treatment plans, and even generate novel therapeutic solutions tailored to individual patients. As these technologies continue to evolve, they reduce the time and cost of medical research and development, making advanced healthcare solutions more accessible. Consequently, the integration of cutting-edge AI technologies is transforming healthcare delivery, driving demand for generative AI applications, and fueling market expansion.

To learn more about this report, download the PDF brochure

Expanding venture funding and other investments in the AI sector to fuel market growth

Growing venture capital (VC) funding and strategic investments are significantly accelerating the adoption of generative AI in healthcare by enabling the development, commercialization, and scaling of innovative AI-powered healthcare solutions. According to the OECD, AI firms attracted USD 258.7 billion in venture capital investments in 2025, accounting for 61% of total global VC investments, more than double AI's share in 2022. Within this, generative AI companies secured USD 35.3 billion, representing over 14% of all AI venture capital investments, reflecting strong investor confidence in foundation models and large language model (LLM)-based applications.

The healthcare sector is emerging as one of the most promising application areas for these investments, particularly across clinical documentation, medical imaging, drug discovery, personalized medicine, clinical decision support, and patient engagement. In addition to venture capital, leading technology companies continue to make substantial strategic investments to strengthen the generative AI ecosystem. For example, Microsoft's multi-billion-dollar partnership with OpenAI has accelerated the integration of generative AI across cloud infrastructure and healthcare solutions, while companies such as Google, Amazon Web Services, NVIDIA, and Oracle continue to expand AI capabilities for life sciences and healthcare. Rising investments enable healthcare AI companies to strengthen research, recruit specialized talent, obtain regulatory approvals, and establish strategic collaborations with healthcare providers and pharmaceutical companies. As investor confidence and enterprise adoption continue to grow, sustained capital inflows are expected to accelerate innovation, commercialization, and global adoption of generative AI technologies across the healthcare industry.

Application Segment Outlook

Drug Discovery and Development is the largest segment due to the extensive use of AI in accelerating the discovery of new drugs, optimizing clinical trials, and reducing time-to-market. This segment benefits from AI’s ability to analyze large datasets, simulate drug interactions, and predict outcomes more efficiently. Growth in the patient assistance and monitoring segment is driven by the rapid advancements in AI-driven virtual assistants and remote monitoring technologies. AI tools are increasingly being used to provide real-time health support, enhance patient engagement, and monitor chronic conditions, making this segment particularly dynamic.

To learn more about this report, download the PDF brochure

End User Segment Outlook

The pharmaceutical & biotechnology companies represent the largest segment. This is due to their extensive use of AI in drug discovery, development, and clinical trials. AI helps these companies streamline processes, enhance precision in drug targeting, and reduce costs, making them the primary adopters of generative AI technologies. The growth in the healthcare providers segment for AI in healthcare is driven by the need for improved patient care and operational efficiency. AI aids in automating administrative tasks, enhancing diagnostic accuracy, and personalizing treatment plans. This technology supports real-time data analysis and decision-making, leading to better patient outcomes and streamlined workflows, thus fueling its adoption among healthcare providers.

Regional Outlook: US expected to be a major growth engine in generative AI in healthcare market

The US is expected to be a major growth engine in the generative AI in healthcare market due to several factors. Firstly, the country’s robust healthcare infrastructure and advanced technology adoption create an ideal environment for AI integration. Major healthcare providers, such as hospitals and clinics, are increasingly embracing AI to enhance patient care, streamline administrative processes, and improve outcomes. Secondly, the US is home to leading AI companies, research institutions, and tech giants like Google, IBM, and NVIDIA, which are heavily investing in AI development and applications tailored for healthcare. This fosters innovation and accelerates the deployment of AI solutions in the medical field. Furthermore, there is significant venture capital funding and government support for AI in healthcare, further driving market growth. Regulatory bodies like the FDA are also adapting frameworks to ensure the safe integration of AI technologies, encouraging more widespread adoption. Overall, the US combines technological leadership, investment, and a supportive regulatory environment, making it a key driver in the global Generative AI healthcare market.

Growth in the APAC generative AI in healthcare market is driven by the rapid adoption of digital health technologies and AI-powered solutions across the region. Significant investments from both private and public sectors are fuelling innovation, while supportive government policies and initiatives are enhancing healthcare infrastructure, making the region a key area for AI-driven healthcare advancements. Additionally, a growing focus on personalized medicine and improving healthcare access in densely populated areas further accelerates market growth.

Competitive Landscape Analysis

The global generative AI in healthcare market is marked by the presence of established and emerging market players such as-

• Amazon Web Services
• Cognizant
• Google LLC
• IBM Corporation
• Meta
• Microsoft Corporation
• NVIDIA
• OpenAI
• Oracle Corporation
• Syntegra

Get a sample report for competitive landscape analysis

Growth strategies adopted by players to establish their foothold in the generative AI in healthcare market

Players operating in this market are adopting various growth strategies such as new product launch; acquisitions; expansions; and strategic partnerships, agreements, and collaborations, to garner market share. For instance,

• In February 2026, Fujitsu Japan launched a generative AI-powered medical documentation solution that automatically converts physician-patient conversations into structured clinical records, reducing administrative burden and improving healthcare workflow efficiency
• In June 2025, the US FDA launched Elsa, an agency-wide generative AI tool that streamlines scientific reviews, clinical evaluations, and regulatory workflows, improving operational efficiency and accelerating healthcare decision-making
• In July 2024, GE HealthCare and Amazon Web Services (AWS) formed a strategic partnership to develop generative AI applications aimed at enhancing medical diagnostics and patient care. GE HealthCare will use AWS’s cloud and AI services to create innovative solutions that improve clinical workflows, diagnostic accuracy, and patient outcomes, accelerating the development and implementation of new healthcare technologies
• In June 2024, Cognizant, in partnership with Google Cloud, launched healthcare-specific generative AI solutions to streamline administrative processes and improve patient care experiences. These AI-driven tools target high-cost workflows, enhancing efficiency, accuracy, and overall healthcare delivery, and manufacturing
• In March 2024, NVIDIA launched over two dozen healthcare microservices, enabling global healthcare enterprises to leverage generative AI for advanced medical applications across any cloud platform
• In February 2024, Hartford HealthCare launched its Center for Artificial Intelligence (AI) Innovation in Healthcare to advance AI research and development in clinical care, collaborating with institutions like MIT and the University of Oxford. The center aims to lead AI-driven healthcare transformation by focusing on collaboration, trustworthiness, and innovation, building on Hartford HealthCare's existing AI initiatives
• In November 2023, Wipro partnered with NVIDIA to enhance healthcare solutions using generative AI, leveraging NVIDIA’s AI Enterprise software for improved member experience, enrolment, and claims processing. This collaboration aims to accelerate the adoption of AI in healthcare, enabling custom AI models and transforming digital and business processes in the industry

Report Scope

Global Generative AI in Healthcare Market Segmentation

This report by Medi-Tech Insights provides the size of the global generative AI in healthcare market at the regional and country-level from 2024 to 2031. The report further segments the market by product & service, application, and end user.

Market Size & Forecast (2024-2031), By Product & Service, USD Billion

• Software
• Services

Market Size & Forecast (2024-2031), By Application, USD Billion

• Drug Discovery and Development
• Medical Research and Data Analysis
• Medical Imaging and Diagnostics
• Patient Assistance and Monitoring
• Personalized Medicine
• Clinical Decision Support
• Healthcare Operations
• Predictive Analytics
• Other Applications

Market Size & Forecast (2024-2031), By End User, USD Billion

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Healthcare Providers
• Healthcare Payers
• Academic & Research Institutes
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa